Table 3 Characteristics of patients with (V)LST.

Discontinuation of clopidogrel, n (%)

20 (100)

Clopidogrel free interval prior to (V)LST (days, median, range)

202 (1433)

Discontinuation of acetylsalicylic acid n (%)

2 (10)

Acetylsalicylic acid free interval prior to (V)LST (days, median, range)

0 (180)

Late Stent thrombosis (6-12 months) n (%)

6 (30)

Very late stent thrombosis (> 12 months) n (%)

14 (70)

Vessel with stent thrombosis

LAD n (%)

12 (60)

CX n (%)

3 (15)

RCA n (%)

5 (25)

Multivessel stenting prior to LST n (%)

3 (15)